v3.21.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash Flows from Operating Activities    
Net loss $ (386,027) $ (13,134,778)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 130,145 84,940
Amortization of convertible debt discounts 8,750 74,775
Change in fair value of derivative liability (1,008,000) 1,381,363
Stock issued for services 32,750 2,870,472
Stock issued under Equity Purchase Agreement 252,900 7,865,077
Changes in assets and liabilities:    
Accounts receivable (61,683) (696,710)
Inventories (109,402) (78,919)
Right of use assets 16,321
Accounts payable 7,847 (1,462,072)
Accrued expenses 382,863 (158,601)
Deferred revenue (139,273) 431,147
Net cash used in operating activities (872,809) (2,823,306)
Cash Flows from Investing Activities    
Purchases of capitalized development costs (4,160)
Cash Flows from Financing Activities    
Principal payments on financing lease obligations (1,392)
Principal payments on notes payable (128,042) (774)
Payments on advances from stockholder, net (13,998) (33,110)
Proceeds from convertible notes payable 840,000
Payments on line of credit, net (4,999) (300,000)
Proceeds from sale of common stock under Equity Purchase Agreement 838,100 2,316,520
Net cash provided by financing activities 689,669 2,822,636
Net Decrease in Cash and Cash Equivalents (187,300) (670)
Cash, Beginning of Period 541,591 412,391
Cash, End of Period 354,291 411,721
Supplemental and Non Cash Disclosures    
Noncash additions related to convertible debt 34,250
Cash paid for interest 37,079 19,986
Interest on shares issued under Equity Purchase Agreement 252,900 4,006,900
Stock issued for services 32,750 2,763,000
Property leased with financing lease 25,317
Accretion of discount and change in fair value of derivatives 999,250 1,029,700
Common stock issued in exchange for convertible debt reduction $ 1,799,510